Human relevance of an in vitro gene signature in HaCaT for skin sensitization

Toxicology in Vitro

Volumn 29, Issue 1, 2015, Pages 81-84

  Van der Veen, Jochem W ^a,b   Hodemaekers, Henny ^a   Reus, Astrid A ^c   Maas, Wilfred J M ^c   van Loveren, Henk ^a,b   Ezendam, Janine ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c TNO   (Netherlands)

Author keywords

Gene signature; HaCaT; Human relevance; Skin sensitization

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ALLERGEN; DIPHENCYPRONE; HEME OXYGENASE 1; PROTEIN C FOS; CYCLOPROPANE DERIVATIVE; TRANSCRIPTOME;

ADM GENE; ADULT; ANKRD37 GENE; ARTICLE; CFOS GENE; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FOSL1 GENE; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE SIGNATURE; HMOX1 GENE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MIDDLE AGED; MOLECULAR DYNAMICS; MOLECULAR GENETICS; RBM5 GENE; SKIN SENSITIZATION; SRXN1 GENE; UPREGULATION; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; KERATINOCYTE; METABOLISM; SKIN; SKIN ALLERGY; YOUNG ADULT;

ADULT; ALLERGENS; CYCLOPROPANES; DERMATITIS, ALLERGIC CONTACT; DINITROCHLOROBENZENE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IN VITRO TECHNIQUES; KERATINOCYTES; MIDDLE AGED; SKIN; TRANSCRIPTOME; YOUNG ADULT;

EID: 84908328389     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.08.010     Document Type: Article

References (15)

1. Adler S., Basketter D., Creton S., et al. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch. Toxicol. 2011, 85(5):367-485.
2. Alloul-Ramdhani M., Tensen C.P., El Ghalbzouri A. Performance of the N/TERT epidermal model for skin sensitizer identification via Nrf2-Keap1-ARE pathway activation. Toxicol. In Vitro 2014, 28(5):982-989.
3. EEC, 2006. Regulation (EC) No1907/2006 of the European Parliament and of the Council. Off. J. Eur. Union L 136/3.
4. EEC, 2008. Council Directive 76/768/EEC.
5. Friedmann P.S., Moss C., Shuster S., et al. Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects. Clin. Exp. Immunol. 1983, 53(3):709-715.
6. Kimber I., Dearman R.J. The local lymph node assay and skin sensitization testing. Meth. Mol. Biol. 2010, 598:221-231.
7. Kimber I., Basketter D.A., Gerberick G.F., et al. Allergic contact dermatitis. Int. Immunopharmacol. 2002, 2(2-3):201-211.
8. McKim J.M., Keller D.J., Gorski J.R. An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing. Cutan. Ocul. Toxicol. 2012, 31(4):292-305.
9. Pedersen M.B., Skov L., Menne T., et al. Gene expression time course in the human skin during elicitation of allergic contact dermatitis. J. Invest. Dermatol. 2007, 127(11):2585-2595.
10. Reus A.A., Usta M., Krul C.A. The use of ex vivo human skin tissue for genotoxicity testing. Toxicol. Appl. Pharmacol. 2012, 261(2):154-163.
11. Schmidt M., Raghavan B., Muller V., et al. Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nat. Immunol. 2010, 11(9):814-819.
12. Sleijffers A., Garssen J., de Gruijl F.R., et al. Influence of ultraviolet B exposure on immune responses following hepatitis B vaccination in human volunteers. J. Invest. Dermatol. 2001, 117(5):1144-1150.
13. van der Veen J.W., Pronk T.E., van Loveren H., et al. Applicability of a keratinocyte gene signature to predict skin sensitizing potential. Toxicol. In Vitro 2013, 27(1):314-322.
14. Vandebriel R.J., van Loveren H. Non-animal sensitization testing: state-of-the-art. Crit. Rev. Toxicol. 2010, 40(5):389-404.
15. Vandebriel R.J., Pennings J.L., Baken K.A., et al. Keratinocyte gene expression profiles discriminate sensitizing and irritating compounds. Toxicol. Sci. 2010, 117(1):81-89.